Navigation Links
Hemostatic drug less effective than originally predicted
Date:11/15/2010

The use of recombinant activated factor 7 (rFVIIa) a drug used to treat bleeding in hemophiliacs in patients without hemophilia is not recommended because of the potential for adverse events, found a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100408.pdf.

Recombinant activated factor 7 is a hemostatic agent licensed for the treatment of bleeding in hemophilia patients. It is also used "off-label" for the prevention and treatment of bleeding in patients without hemophilia including patients undergoing surgery, liver transplants and other procedures.

The use of rFVIIa in people without hemophilia appears to be common. For example, out of more than 2700 cases in the Australian and New Zealand Hemostasis Registry that use rFVIIa, only 1% had a diagnosis of hemophilia.

This systematic review was conducted to analyze the effectiveness and risks of rFVIIa in patients without hemophilia and to assess the implications of these results for future research.

"Physicians must believe that 'off-label' use is effective and outweighs risks," write Dr. Yulia Lin, Sunnybrook Health Sciences Centre and coauthors. "However, randomized controlled trials (RCTs) evaluating rFVIIa have raised concerns about adverse effects, particularly thromboembolic events (blood clots)."

The review, which looked at 14 prophylactic use RCTs including 1137 patients and 12 therapeutic use RCTs with 2538 patients, found uncertainty about the benefits and harms of this therapy.

"Clinically significant benefits of rFVIIa as a more general hemostatic drug (outside of hemophilia) remain unproven," conclude the authors. "This systematic review has not shown a consistent benefit of off-label rFVIIa use in the therapeutic setting and (at best) only modest benefits in the prophylactic setting. Given the potential risks, it cannot be recommended and in most cases, its use should be restricted to a clinical trial."


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Related medicine news :

1. Hemostatic powder stops bleeding ulcers: Doctor
2. New Malaria Drug Proves Effective in Study of African Children
3. 5-year results show keyhole bowel cancer surgery is safe and effective
4. New lymphoma therapy may be more effective with fewer side effects
5. Diverse surgeons initiative effectively increases underrepresented minorities in academic surgery
6. Gene Mutations May Blunt Plavixs Effectiveness, Study Finds
7. Newer, more intense chemotherapy with less radiation not more effective against Hodgkins lymphoma
8. Parent-only treatment may be equally effective for children who are obese
9. Home Monitoring of Blood-Thinner Use Appears Effective
10. Conventional, annual Pap smear cost-effective follow-up after cervical lesion treatment
11. Proton therapy safe, effective for early-stage lung cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2020)... ... 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many ... to trim the fat from our monthly expenses and put more into savings, if possible. ... you have a financial safety net in place in case something were to happen to ...
(Date:8/31/2020)... ... 31, 2020 , ... Bonde Innovations, LLC, a venture-backed developer ... failure, today announced that the company has been awarded a Phase 1 Small ... Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). The ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... ... a one-year subscription to a customized Lighthouse Health & Wellness mobile app and ... of this project. Motorola Solutions Foundation awards grants each year to organizations, such ...
(Date:8/28/2020)... ... August 28, 2020 , ... A July 27 ... obese individuals are at an increased risk of developing severe COVID-19 symptoms. The ... COVID-19; however, because the same organ systems that the coronavirus attacks are already ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... at the upcoming Global Inclusion Online Forum, leading a session entitled, “A CEO ... online event of this magnitude designed to bring together the world’s leading diversity ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... Va. (PRWEB) , ... September 03, 2020 , ... Using ... An FDAnews Webinar, Thursday, Sept. 17, 2020, 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/anova ... an expert statistician? , While one can’t become one in 90 minutes, one ...
(Date:9/1/2020)... ... September 01, 2020 , ... Agilent, a global leader ... Science and Technology Virtual Symposium 2020 (ASTVS 2020) on September 10-11, opening ... of Live webinars and Networking sessions, with a vast array of on-demand presentations ...
(Date:9/1/2020)... ... September 01, 2020 , ... September is National Ovarian Cancer Awareness ... deaths than any other cancer of the female reproductive system. The American Cancer ... and about 14,000 women will die from this disease. Throughout the month of ...
Breaking Medicine Technology: